Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort
Recruiting
Observational Study
Immunosenescence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 60 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 484 (estimated)
- Sponsor
- Huashan Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective observational cohort study aims to investigate the relationship between immunosenescence and infectious diseases in older adults. Individuals aged 60 years and older, including elderly patients with infections and healthy controls, will be enrolled and followed longitudinally.
Clinical information, laboratory test results, and health assessment data will be collected. Biological …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria for the Healthy Control Group
1. No clinical symptoms suggestive of infection, including fever, cough, dyspnea, fatigue, or myalgia.
2. No abnormal physical signs, including lymphadenopathy, hepatomegaly, splenomegaly, or skin rash.
3. Normal laboratory test results, including co…
Contacts